載入...
Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer
Pancreatic cancer is one of the most lethal types of malignant solid tumor and is typically associated with a poor prognosis. The majority of patients are diagnosed with advanced-stage disease, therefore, the median survival period is <6 months. Recently, a number of basic research projects and c...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734067/ https://ncbi.nlm.nih.gov/pubmed/26893699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.4009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|